Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Total Costs & Expenses

$578.40M

Quarterly · Period ending: Jun 30, 2026 · USD

BIO Total Costs & Expenses

Latest reported$578.40Mperiod endingJun 30, 2026

BIO Quarterly Total Costs & Expenses ($0.00 → $578.40M)

Quarterly Total Costs & Expenses

High-resolution chart · PNG

BIO total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Total Costs & Expenses — Quarterly (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2026	578,400,000
Mar 31, 2026	558,000,000
Dec 31, 2025	630,700,000
Sep 30, 2025	587,700,000
Jun 30, 2025	574,500,000
Mar 31, 2025	561,700,000
Dec 31, 2024	609,145,000
Sep 30, 2024	585,263,000
Jun 30, 2024	538,180,000
Mar 31, 2024	558,812,000
Dec 31, 2023	583,393,000
Sep 30, 2023	541,175,000
Jun 30, 2023	591,493,000
Mar 31, 2023	614,931,000
Dec 31, 2022	611,618,000
Sep 30, 2022	588,004,000
Jun 30, 2022	570,882,000
Mar 31, 2022	553,654,000
Dec 31, 2021	625,787,000
Sep 30, 2021	590,245,000
Jun 30, 2021	591,149,000
Mar 31, 2021	625,934,000
Dec 31, 2020	614,597,000
Sep 30, 2020	537,663,000
Jun 30, 2020	485,138,000
Mar 31, 2020	497,271,000
Dec 31, 2019	565,223,000
Sep 30, 2019	503,173,000
Jun 30, 2019	516,229,000
Mar 31, 2019	497,373,000
Dec 31, 2018	549,382,000
Sep 30, 2018	508,863,000
Jun 30, 2018	532,119,000
Mar 31, 2018	507,873,000
Dec 31, 2017	561,864,000
Sep 30, 2017	488,624,000
Jun 30, 2017	507,017,000
Mar 31, 2017	474,492,000
Dec 31, 2016	534,659,000
Sep 30, 2016	480,652,000
Jun 30, 2016	494,252,000
Mar 31, 2016	445,470,000
Dec 31, 2015	511,074,000
Sep 30, 2015	437,290,000
Jun 30, 2015	465,897,000
Mar 31, 2015	438,472,000
Dec 31, 2014	547,638,000
Sep 30, 2014	497,404,000
Jun 30, 2014	491,145,000
Mar 31, 2014	488,873,000
Dec 31, 2013	550,318,000
Sep 30, 2013	476,008,000
Jun 30, 2013	473,775,000
Mar 31, 2013	466,118,000
Dec 31, 2012	501,638,000
Sep 30, 2012	434,465,000
Jun 30, 2012	437,114,000
Mar 31, 2012	431,911,000
Dec 31, 2011	464,308,000
Sep 30, 2011	442,592,000
Jun 30, 2011	453,470,000
Mar 31, 2011	418,003,000
Dec 31, 2010	455,936,000
Sep 30, 2010	396,700,000
Jun 30, 2010	399,486,000
Mar 31, 2010	390,987,000
Dec 31, 2009	434,976,000
Sep 30, 2009	393,684,000
Jun 30, 2009	371,298,000
Mar 31, 2009	349,496,000
Dec 31, 2008	396,906,000
Sep 30, 2008	390,648,000
Jun 30, 2008	392,653,000
Mar 31, 2008	372,458,000
Dec 31, 2007	428,900,000
Sep 30, 2007	302,217,000
Jun 30, 2007	303,428,000
Mar 31, 2007	283,658,000
Dec 31, 2006	313,313,000
Sep 30, 2006	274,913,000
Jun 30, 2006	274,522,000
Mar 31, 2006	260,971,000
Dec 31, 2005	285,397,000
Sep 30, 2005	257,824,000
Jun 30, 2005	263,380,000
Mar 31, 2005	259,086,000
Dec 31, 2004	282,243,000
Sep 30, 2004	232,800,000
Jun 30, 2004	226,629,000
Mar 31, 2004	230,482,000
Dec 31, 2003	232,546,000
Sep 30, 2003	214,411,000
Jun 30, 2003	208,860,000
Mar 31, 2003	201,803,000
Dec 31, 2002	209,593,000
Sep 30, 2002	189,255,000
Jun 30, 2002	181,678,000
Mar 31, 2002	174,740,000
Dec 31, 2001	198,938,000
Sep 30, 2001	165,546,000